Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept

F. Kaya

Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept

2017

F. Kaya

To compare the changes in subfoveal choroidal thickness after intravitreal ranibizumab or aflibercept injections for neovascular age-related macular degeneration (nAMD).

Keywords:

Surgery
Ranibizumab
Macular degeneration
Aflibercept
Medicine
Visual acuity
in patient
Ophthalmology
age related
Choroid
significant difference

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations